Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 80 of 95, showing 5 Applications out of 471 total, starting on record 396, ending on 400

# Protocol No Study Title Investigator(s) & Site(s)

396.

ECCT/16/11/02   IMPAACT P1093
    Phase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of Dolutegravir, a Novel Integrase Inhibitor, in Combination Regimens in HIV-1 Infected Infants, Children and AdolescentsPhase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of Dolutegravir, a Novel Integrase Inhibitor, in Combination Regimens in HIV-1 Infected Infants, Children and Adolescents   
Principal Investigator(s)
1. Lucy Koech
Site(s) in Kenya
KENYA MEDICAL RESEARCH INSTITUTE/WALTER REED PROJECT HIV PROGRAME
 
View

397.

ECCT/16/12/03   The Partners Scale-Up Project
    An implementation project to scale-up delivery of antiretroviral-based HIV-1 prevention among Kenyan HIV-1 serodiscordant couples   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
1. Thika Level 5 Hospital, Ruiru Sub-County Hospital, Kiambu County Hospital, Kikuyu PCEA Hospital (Kiambu county)
2. Coptic Hospital, Mbagathi Hospital, St. Mary\'s Hospital, Pumwani Maternity Hospital (Nairobi City county)
3. Nyeri PGH, Karatina Sub-County Hospital, (Nyeri county)
4. Kerugoya County Hospital (Kirinyaga county)
5. Murang\'a County Hospital (Murang\'a county)
 
View

398.

ECCT/22/09/04   SAPPHIRE STUDY
    A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa   
Principal Investigator(s)
1. Elizabeth Anne Bukusi
Site(s) in Kenya
KEMRI-SEARCH SAPPHIRE
 
View

399.

ECCT/16/05/02   Monitoring Pre-exposure Prophylaxis for Young Adult women (MPYA)
    Next generation real-time monitoring for PrEP adherence in young Kenyan women   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
1. Thika Partners Study Clinic (Partners in Health Research and Development) (Kiambu county)
2. Partners in Prevention, Kisumu Site (Kisumu county)
 
View

400.

ECCT/22/03/01   The \"NOVATION-1\" Trial
    A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Evaluate the Safety and Efficacy of Aerosolized Novaferon + SOC vs. Placebo + SOC in Hospitalized Adult Patients with Moderate to Severe COVID-19   
Principal Investigator(s)
1. Dr John Kinuthia
Site(s) in Kenya
1. Center for Research in Therapeutic Sciences(CREATES) (Nairobi City county)
2. Victoria Biomedical Research Institute (VIBRI) (Kisumu county)
3. KEMRI Kericho (Kericho county)
4. KEMRI Siaya (Kisumu county)
5. Kenyatta National Hospital (Nairobi City county)
 
View